timothy sykes logo
Catheter Precision VTAK Builds AI Aviation Bet With Volato Stake Thumbnail
G Google News

Catheter Precision VTAK Builds AI Aviation Bet With Volato Stake

MATT MONACO•UPDATED JUN. 24, 2026, 9:18 AM ET
Reviewed by Jack Kelloggand Fact-checked by Tim Sykes

Catheter Precision Inc. stocks have been trading up by 48.91 percent after positive news on its cardiac ablation technology.

Key Takeaways

  • Led through its Flyte unit, Catheter Precision took a 7.5% Volato stake, becoming the private aviation firm’s largest shareholder.
  • The company led a $2.2M strategic PIPE into Volato to back AI-enabled private aviation and regional air mobility projects.
  • Flyte partnered with GSE Worldwide and PGA TOUR golfer Emiliano Grillo to promote its Cirrus Vision Jet short-haul service at the 2026 U.S. Open.
  • VTAK is highlighted as Flyte’s acquirer from Creatd, which still holds meaningful economic ties to the aviation business.
  • Shares of Catheter Precision (VTAK) jumped nearly 3% after the Volato financing and equity stake were announced.

Candlestick Chart

Live Update At 09:18:24 EDT: On Wednesday, June 24, 2026 Catheter Precision Inc. stock [NYSE American: VTAK] is trending up by 48.91%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

VTAK is trading like a classic small-cap story stock. The daily chart shows a choppy slide from roughly $1.08–$1.10 in early 2026/06 down to $0.92 by 2026/06/23, with repeated failed pushes over $1.05. That tells traders supply keeps showing up near the $1 area. The intraday tape, however, shows heavy premarket range between $1.10 and nearly $2.00, a huge volatility band that momentum traders live for.

Fundamentally, Catheter Precision is high risk. Revenue for the latest quarter sits at just $432,000 and $819,000 on a trailing basis, while net income is deep in the red at about -$1.68M for the quarter. Profitability ratios are brutal: EBITDA margin and net margins are sharply negative, and return on equity and assets are deeply below zero. VTAK is burning cash, with free cash flow around -$2.8M for the quarter.

More Breaking News

On the balance sheet, Catheter Precision shows only $441,000 in cash against $6.8M in current debt and a current ratio of 0.1. That is tight. Yet the market values VTAK at only about 0.27 times book value, signaling traders are discounting the whole story heavily. For active traders, that mix—low price, poor fundamentals, and big news-driven spikes—screams “trade the chart, not the story.”

Why Traders Are Watching VTAK’s Flyte And Volato Moves

Catheter Precision is known mainly as a medical technology name, but VTAK is quietly building a second act in aviation through its Flyte subsidiary. That pivot is what has traders paying attention. Flyte stepped in to lead a broader financing for Volato, scooping up about 2.9M Volato (SOAR) shares and locking down a 7.5% stake. That makes Flyte Volato’s largest shareholder, and the market liked the move enough to push VTAK shares up nearly 3% on the news.

This is not some passive toe-dip. Catheter Precision, as Flyte’s parent, also led a $2.2M strategic PIPE into Volato. Management is clearly signaling it wants Flyte and Volato to collaborate across an AI-enabled private aviation ecosystem, tying together aircraft utilization, regional air mobility routes, and digital infrastructure. For traders, that builds a speculative “AI plus aviation” narrative layered on top of a tiny-cap balance sheet.

VTAK is also pushing brand exposure. Flyte partnered with sports marketing shop GSE Worldwide and PGA TOUR pro Emiliano Grillo, rolling out the relationship at the 2026 U.S. Open. The focus: marketing Flyte’s Cirrus Vision Jet-based short-haul service to pro athletes and the wider sports world. That’s classic niche positioning—going after high-value, time-sensitive clientele where convenience matters more than price.

Behind it all, Catheter Precision’s ownership of Flyte traces back to an acquisition from Creatd. VTAK remains a major client and strategic partner to Creatd, which still holds equity, preferred stock, and note receivables tied to the Flyte deal. For traders, that means the Flyte story is financially layered, with cross-company ties that could magnify both upside and downside if the aviation push works—or stalls.

Conclusion

For active traders, VTAK now sits at the crossroads of two very different stories: a cash-hungry core business with weak margins, and a high-concept aviation platform trying to ride AI and regional air mobility trends. The Volato stake and PIPE show Catheter Precision is willing to write meaningful checks to secure a role in that ecosystem. The sports-focused marketing push with GSE Worldwide and Emiliano Grillo suggests Flyte is serious about chasing premium demand, not just talking about technology.

The chart backs up how binary this kind of name can trade. VTAK has already shown it can rip nearly 100% intraday and then fade hard once the initial news rush cools. With a low share price, heavy losses, and thin cash, every headline around Flyte, Volato, or any new financing round becomes a potential catalyst.

Traders in the Tim Sykes community typically treat stocks like VTAK as educational case studies in momentum, gap moves, and risk control—not as long-term holdings. The goal is to recognize when volume and news align, then manage risk ruthlessly. As Tim Sykes often says, “The market doesn’t care about your hopes, only your plan.” That plan also reflects his emphasis on process and discipline over lottery-ticket mentality. As millionaire penny stock trader and teacher Tim Sykes, says, “Small gains add up over time; focus on building wealth gradually, not chasing jackpots.”. For anyone tracking Catheter Precision and its Flyte and Volato bets, that plan starts with respecting the volatility and cutting losses fast. This coverage is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Click Here for a Millionaire's POV on Trading TICKER

Millionaire's
POV on TICKER

Don't miss the next
big breakout.

GET POV
Tim Sykes

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”